Anna Fagotti

Associate Professor

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Anna Fagotti is an Associate Professor at the Policlinico Universitario Agostino Gemelli IRCCS, Catholic University of the Sacred Heart in Italy. Her research primarily focuses on the application of artificial intelligence in oncology, particularly in the fields of endometrial and ovarian cancer. Recent publications include systematic reviews and studies on the role of genomic analysis, surgical procedures, and chemotherapy treatments in cancer management.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (5)

Berta Díaz-Feijoo

PROFESORA ASOCIADA

University of Barcelona

SPAIN

View details

Luciano Giaco'

Head of Bioinformatics

Policlinico Universitario Agostino Gemelli

ITALY

View details

alfredo ercoli

ITALY

View details

Francesco Fanfani

Associate Professor

Università Cattolica del Sacro Cuore

ITALY

View details

Carlo Ronsini

University of Campania “Luigi Vanvitelli”

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna Fagotti

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Role of artificial intelligence applied to ultrasound in endometrial cancer: a systematic review

Detection of Clinically Significant BRCA Large Genomic Rearrangements in FFPE Ovarian Cancer Samples: A Comparative NGS Study

Platinum-rechallenge in epithelial ovarian cancer relapsing within 6 months after first-line treatment: a propensity score matching analysis

Reply to the comment by Signorelli et al. on the article “Correspondence on Laparoscopic tumor load as an independent prognostic marker in advanced ovarian cancer: a 3-year cohort study by Marco D'Indinosante et al. “

Laparoscopic tumor load as an independent prognostic marker in advanced ovarian cancer: a 3-year cohort study

Extending the timing for secondary cytoreductive surgery after second-line chemotherapy in relapsed ovarian cancer: the EXTENSION study

Reply to: Reflections on the HORSE Trial: Hyperthermic Intraperitoneal Chemotherapy, BRCA Status, and Clinical Implications

Critical view of safety assessment in sentinel node dissection for endometrial and cervical cancer: artificial intelligence to enhance surgical safety and lymph node detection (LYSE study)

Efficacy of Neoadjuvant Chemotherapy as pre-habilitation program in advanced epithelial ovarian cancer

In memoriam: Giovanni Scambia (1959-2025)

Consensus on the Gemelli terminology of surgical anatomy for radical hysterectomy

PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study

Sentinel lymph node biopsy in ovarian cancer: more questions than certainties

PARP inhibitors in epithelial ovarian cancer: what are their potential implications for surgical management?

Rucaparib Maintenance in Upfront Ovarian Cancer: The Long-Lasting Challenge of Predicting Response to Poly (ADP-ribose) Polymerase Inhibitors

Healthcare associated infections in gynecologic oncology: clinical and economic impact

Minimally invasive versus open pelvic exenteration in gynecological malignancies: a propensity-matched survival analysis

Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer

Trabectedin plus pegylated liposomal doxorubicin in patients with disease progression after PARP inhibitor maintenance: a real-life case–control study

Transvaginal ultrasound-guided biopsy in patients with suspicious primary advanced tubo-ovarian carcinoma

Collaborators (5)

Berta Díaz-Feijoo

Luciano Giaco'

alfredo ercoli

Francesco Fanfani

Carlo Ronsini

Make your next move.